Portfolio company
Kanvas Biosciences
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
3 investors
Sectors
About
This company develops microbiome mapping platforms and live biotherapeutic products for pharmaceutical companies and research institutions focused on treating cancer and inflammatory diseases.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
KANVAS
This company develops spatial biology imaging technology and microbiome-based therapeutics for healthcare providers treating cancer and infectious diseases.
mbiomics
This company develops live bacterial therapeutics and a microbiome profiling platform to treat patients with cancer and inflammatory bowel diseases.
KOBIOLABS
This company develops microbiome-derived therapeutics and live biotherapeutic products for patients with immune, metabolic, neurological and gastrointestinal diseases.
Exomnis Biotech
This company develops engineered bacteria as delivery vehicles for cancer immunotherapies, serving pharmaceutical companies and clinical researchers.
Microbiotica
This company develops live bacterial therapeutics and biomarkers for patients with inflammatory bowel disease and advanced melanoma.
Laguna Biosciences
This biotechnology company develops microbial platforms to activate the innate immune system for pharmaceutical partners treating cancer patients.
Concerto BioSciences
This company develops microbe-based ingredients and therapeutics for skincare and healthcare companies using a combinatorial screening platform to map microbial interactions.
Vedanta Biosciences
This company develops microbiome-based oral therapies using bacterial consortia to treat patients with gastrointestinal and immune-mediated diseases.
